BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 37082943)

  • 1. Double-faced CX3CL1 enhances lymphangiogenesis-dependent metastasis in an aggressive subclone of oral squamous cell carcinoma.
    Eain HS; Kawai H; Nakayama M; Oo MW; Ohara T; Fukuhara Y; Takabatake K; Shan Q; Soe Y; Ono K; Nakano K; Mizukawa N; Iida S; Nagatsuka H
    JCI Insight; 2024 May; 9(10):. PubMed ID: 38775151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porphyromonas gingivalis promotes the progression of oral squamous cell carcinoma by activating the neutrophil chemotaxis in the tumour microenvironment.
    Guo ZC; Jing SL; Jumatai S; Gong ZC
    Cancer Immunol Immunother; 2023 Jun; 72(6):1523-1539. PubMed ID: 36513851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CX3CL1 and its receptor CX3CR1 interact with RhoA signaling to induce paclitaxel resistance in gastric cancer.
    Liu X; Yu Z; Li Y; Huang J
    Heliyon; 2024 Apr; 10(7):e29100. PubMed ID: 38601629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-36 antagonism blunts the proliferation and migration of oral squamous cell carcinoma cells.
    Li Z; Zhang X; Li K; Li F; Kou J; Wang Y; Wei X; Sun Y; Jing Y; Song Y; Yu Q; Yu H; Wang S; Chen S; Wang Y; Xie S; Zhu X; Zhan Y; Sun G; Ni Y
    Cell Signal; 2024 May; 117():111096. PubMed ID: 38346528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between aggressive features of oral squamous cell carcinoma and the immunoexpression of CX3CR1, CX3CL1 and ITGAV.
    Martínez-Flores R; Lozano-Burgos C; Niklander SE; Fernández-Cuya M; Lopes MA; González-Arriagada WA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Apr; ():. PubMed ID: 38760287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maackia amurensis seed lectin (MASL) and soluble human podoplanin (shPDPN) sequence analysis and effects on human oral squamous cell carcinoma (OSCC) cell migration and viability.
    Yin AC; Holdcraft CJ; Brace EJ; Hellmig TJ; Basu S; Parikh S; Jachimowska K; Kalyoussef E; Roden D; Baredes S; Capitle EM; Suster DI; Shienbaum AJ; Zhao C; Zheng H; Balcaen K; Devos S; Haustraete J; Fatahzadeh M; Goldberg GS
    Biochem Biophys Res Commun; 2024 May; 710():149881. PubMed ID: 38583233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cytokine CX3CL1 and ADAMs/MMPs in Concerted Cross-Talk Influencing Neurodegenerative Diseases.
    Iemmolo M; Ghersi G; Bivona G
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CX3CL1 (Fractalkine)-CX3CR1 Axis in Inflammation-Induced Angiogenesis and Tumorigenesis.
    Szukiewicz D
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a novel prognostic model in skin cutaneous melanoma based on chemokines-related gene signature.
    Ding X; Wang W; Tao X; Li Z; Huang Y
    Sci Rep; 2023 Oct; 13(1):18172. PubMed ID: 37875556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CX3CL1 promotes M1 macrophage polarization and osteoclast differentiation through NF-κB signaling pathway in ankylosing spondylitis in vitro.
    Feng X; Zhu S; Qiao J; Ji Z; Zhou B; Xu W
    J Transl Med; 2023 Aug; 21(1):573. PubMed ID: 37626378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAM17-regulated CX3CL1 expression produced by bone marrow endothelial cells promotes spinal metastasis from hepatocellular carcinoma.
    Sun C; Hu A; Wang S; Tian B; Jiang L; Liang Y; Wang H; Dong J
    Int J Oncol; 2020 Jul; 57(1):249-263. PubMed ID: 32319605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and Function of Ligand CX3CL1 and its Receptor CX3CR1 in Cancer.
    Lu X
    Curr Med Chem; 2022; 29(41):6228-6246. PubMed ID: 35770395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biogenic Analysis of the Effect of TERC on Cell Proliferation and Migration of Oral Squamous Cell Carcinoma under Digital Minimally Invasive Treatment.
    Chen W; Zhang Z; Jin Y; Zeng R; Sun X; Zhou Z; Kasim K; Grant J; Kuraki V; Schmid F; Lucas G
    Biomed Res Int; 2022; 2022():2102795. PubMed ID: 36033580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CX3CL1 induces cell migration and invasion through ICAM-1 expression in oral squamous cell carcinoma cells.
    Wu CY; Peng PW; Renn TY; Lee CJ; Chang TM; Wei AI; Liu JF
    J Cell Mol Med; 2023 Jun; 27(11):1509-1522. PubMed ID: 37082943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syk/JNK/AP-1 signaling pathway mediates interleukin-6-promoted cell migration in oral squamous cell carcinoma.
    Chuang JY; Huang YL; Yen WL; Chiang IP; Tsai MH; Tang CH
    Int J Mol Sci; 2014 Jan; 15(1):545-59. PubMed ID: 24398980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vertebral-specific activation of the CX3CL1/ICAM-1 signaling network mediates non-small-cell lung cancer spinal metastasis by engaging tumor cell-vertebral bone marrow endothelial cell interactions.
    Wang K; Jiang L; Hu A; Sun C; Zhou L; Huang Y; Chen Q; Dong J; Zhou X; Zhang F
    Theranostics; 2021; 11(10):4770-4789. PubMed ID: 33754027
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.